0001415889-24-019344.txt : 20240708 0001415889-24-019344.hdr.sgml : 20240708 20240708163014 ACCESSION NUMBER: 0001415889-24-019344 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240219 FILED AS OF DATE: 20240708 DATE AS OF CHANGE: 20240708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cappello Joseph CENTRAL INDEX KEY: 0001939198 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41599 FILM NUMBER: 241105075 MAIL ADDRESS: STREET 1: C/O GENELUX CORPORATION STREET 2: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENELUX Corp CENTRAL INDEX KEY: 0001231457 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 805-267-9889 MAIL ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENELUX CORP DATE OF NAME CHANGE: 20030508 4 1 form4-07082024_040711.xml X0508 4 2024-02-19 0001231457 GENELUX Corp GNLX 0001939198 Cappello Joseph C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 false true false false VP, Pharmaceutical Development 0 Common Stock 2024-02-19 4 A 0 3661 0 A 9396 D Common Stock 2024-03-14 4 A 0 11557 0 A 20953 D Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024. Represents RSUs that are fully vested as of March 14, 2024. /s/ Sean Ryder, Esq., Attorney-in-Fact 2024-07-08